spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  GEM 21S 

 HSMN NewsFeed - 27 Oct 2022
Geistlich Pharma North America, Inc. Acquires Lynch Biologics, LLC, a Biologics and Tissue Engineering Company
Regenerative Medicine Surgery Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2018
LYNCH Biologics Closes on Transaction to Purchase GEM 21S(R) Growth Factor Enhanced Matrix for Dental Bone Regeneration
Devices Biopharmaceuticals Dental Acquisitions
 HSMN NewsFeed - 31 Jan 2011
BioMimetic Therapeutics Announces Date of FDA Advisory Panel Review of Augment(TM) Bone Graft
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 30 Jul 2009
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 21 Apr 2008
BioMimetic Therapeutics Receives Written Communication from FDA Confirming Status of Ongoing Pivotal Trial for GEM OS1
Devices Orthopaedic
 HSMN NewsFeed - 27 Mar 2008
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 13 Dec 2007
BioMimetic Therapeutics Reports Positive Clinical Results for GEM OS(R)1 in Canadian Foot and Ankle Fusion Study
Devices Orthopaedic
 HSMN NewsFeed - 13 Jul 2007
BioMimetic Therapeutics' Clinical Investigator Presents Positive Interim Data on U.S. and Canadian Foot and Ankle Clinical Trials
Devices Orthopaedic
 HSMN NewsFeed - 21 Feb 2007
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jan 2007
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS(R)1 to Treat Distal Radius Fractures
Devices Orthopaedic
 HSMN NewsFeed - 13 Dec 2006
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
Devices Orthopaedic
 HSMN NewsFeed - 13 Oct 2006
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity for GEM 21S(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Sep 2006
BioMimetic Therapeutics Adds Key Talent to Board of Directors
Devices Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 3 additional stories matching:
GEM 21S
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.